-
Patterns of relative INSTI susceptibility for 1,536 viruses in HIVDB with 209...
Patterns of relative INSTI susceptibility for 1,536 viruses in HIVDB with 209 distinct INSTI-Resistance patterns*. -
(a,b,c) Multivariable Cox regression analysis assessing factors associated wi...
(a,b,c) Multivariable Cox regression analysis assessing factors associated with tenofovir discontinuation regardless of the reason, because of toxicity and with selective... -
Composition of the NRTI back-bone of the regimen started after the discontinu...
Composition of the NRTI back-bone of the regimen started after the discontinuation of tenofovir (rows), according to the initial third drug (columns)–All tenofovir... -
r37980778c78--c1e6983091d569b33be56a6d9bc2335a
In vitro susceptibilities associated with the 14 INSTI drug resistance mutation patterns. -
r37980778c78--cb79ae4cf8666b4d8edf836e0b85f111
Patterns of predicted relative NRTI susceptibility profiles for 35,377 viruses in HIVDB with 4,749 Distinct NRTI-Resistance patterns*. -
r37980778c78--33a9256ef5b5ad334325078929949e16
Treatment-emergent substitutions: Participants meeting drug-resistance testing criteria. -
r37980778c78--9c8192770fd940dd459eebea74c98cdd
Proportion of responders with HIV-1 RNA <40 copies/mL (Week 24 snapshot) (mITT). -
Safety, efficacy, and dose response of the maturation inhibitor GSK3532795 (f...
GSK3532795 (formerly known as BMS-955176) is a second-generation maturation inhibitor targeting a specific Gag cleavage site between capsid p24 and spacer peptide 1 of HIV-1.... -
r37980778c78--3d2f6875b6a1c3fda9028e5289276a9b
In vitro susceptibilities associated with the 13 NRTI drug resistance mutation (DRM) patterns. -
r37980778c78--dca60cdc3b40066b8083c884a6bbc3c7
Factors associated with rates of serum creatinine monitoring after ART initiation. -
r37980778c78--0ae2e73d0d5414510d2f0d77abe3eb2b
In vitro susceptibilities associated with the 9 NNRTI drug resistance mutation patterns. -
r37980778c78--b92ebd0ffb6ddf60ec649e3e4be96a1b
The pharmacokinetic properties of tenofovir (TFV) and other charged nucleoside analogues are dramatically improved upon conjugation to a lipid prodrug. We previously prepared... -
Patterns of predicted relative PI susceptibility profiles for 19,379 viruses ...
Patterns of predicted relative PI susceptibility profiles for 19,379 viruses in HIVDB with 5,634 distinct PI-Resistance patterns*. -
Renal Dysfunction during Tenofovir Use in a Regional Cohort of HIV-Infected I...
BackgroundIn resource-limited settings, routine monitoring of renal function during antiretroviral therapy (ART) has not been recommended. However, concerns for tenofovir... -
Comparison of the HIVDB version 7.0, expert panel median, and eventual HIVDB ...
Comparison of the HIVDB version 7.0, expert panel median, and eventual HIVDB version 8.1 levels for the 20 DRM pattern / ARV combinations with a difference between HIVDB version... -
r37980778c78--2cb724a19dd9e3803797e45fb4972150
List of antiretroviral (ARV) drugs and their abbreviations by ARV class.